This inventor holds 1 USPTO granted patent. Top assignee: Amgen Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Thomas Wolfe - Innovator in AAV Vector Production
Introduction
Thomas Wolfe is a notable inventor based in Simi Valley, CA (US). He has made significant contributions to the field of biotechnology, particularly in the production of recombinant AAV vectors. His innovative work has implications for gene therapy and other medical applications.
Latest Patents
Thomas Wolfe holds a patent for "High titer recombinant AAV vector production in adherent and suspension cells." This invention is directed to an in vitro method of producing a recombinant AAV virion in a mammalian host cell that comprises a functional adenoviral E1A gene. The method involves transfecting host cells with varying ratios of plasmids that include the E1A gene and virions. He has 1 patent to his name.
Career Highlights
Wolfe is currently employed at Amgen Inc., a leading biotechnology company. His work at Amgen focuses on advancing the production techniques for AAV vectors, which are crucial for various therapeutic applications.
Collaborations
Throughout his career, Thomas has collaborated with talented individuals such as Huiren Zhao and Grace Ki Jeong Lee. These collaborations have further enhanced the research and development efforts in the field of gene therapy.
Conclusion
Thomas Wolfe's contributions to the field of biotechnology, particularly in AAV vector production, highlight his innovative spirit and dedication to advancing medical science. His work continues to pave the way for future developments in gene therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile